Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT00167128
Previous Study | Return to List | Next Study

The Phonak EduLink-System in Students With Specific Performance Deficits in Speech-in-Noise Intelligibility

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00167128
Recruitment Status : Unknown
Verified May 2006 by University Hospital Muenster.
Recruitment status was:  Recruiting
First Posted : September 14, 2005
Last Update Posted : August 15, 2007
Sponsor:
Collaborator:
Phonak AG, Switzerland
Information provided by:
University Hospital Muenster

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:

In the management and remediation of students with specific performance deficits in speech-in-noise intelligibility, most often, a "triad" approach for treatment is used, which includes direct therapy, compensatory strategies, and environmental modifications.

The purpose of the study is to determine whether a new hearing aid, the Phonak EduLink-FM System, can improve specific performance deficits in speech-in-noise intelligibility. Participants will complete a test battery related to auditory processing, as well as some psychological tests and questionnaires. One group of participants with specific performance deficits in speech-in-noise intelligibility will receive the hearing aid for use in school; a second group will not. The effect of this treatment on auditory performance, school performance and satisfaction, attention and verbal learning and memory, self concept, behavior and listening effort following 26 weeks of hearing aid use will be compared across the groups.


Condition or disease Intervention/treatment Phase
Auditory Processing Disorder Device: hearing aid, Phonak EduLink-FM System Not Applicable

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 30 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: The Phonak EduLink-System in Students With Specific Performance Deficits in Speech-in-Noise Intelligibility
Study Start Date : March 2005

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Hearing Aids Noise

Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. auditory performance [ Time Frame: following 26 weeks hearing aid use ]
  2. school performance and satisfaction [ Time Frame: following 26 weeks hearing aid use ]
  3. attention [ Time Frame: following 26 weeks hearing aid use ]
  4. verbal learning and memory [ Time Frame: following 26 weeks hearing aid use ]

Secondary Outcome Measures :
  1. self concept [ Time Frame: following 26 weeks hearing aid use ]
  2. behavior [ Time Frame: following 26 weeks hearing aid use ]
  3. listening effort [ Time Frame: following 26 weeks hearing aid use ]

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   6 Years to 11 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Diagnosis of specific performance deficits in speech-in-noise intelligibility based on two or more standardized tests of auditory processing in noise including retests.
  • Students in the 1st to 4th class of primary school

Exclusion Criteria:

  • Hearing loss, defined as:

    • Air conduction pure tone thresholds (250-8000 Hz) exceeding 20 dBHL
    • Air-bone gaps, even in the presence of normal sensitivity, exceeding 10 dBHL
    • Abnormal tympanogram
  • History or diagnosis of behavioral and/or emotional disorders meeting ICD-GM-criteria (including attention deficit/hyperactivity disorders (AD-/HD)
  • Non-German speaking
  • Cognitively impaired children (IQ < 85)
  • Children currently using psychoactive medication
  • Students with special education
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00167128


Contacts
Layout table for location contacts
Contact: Peter Matulat +49(0)251 83 ext 56898 matulat@uni-muenster.de
Contact: Antoinette G Dinnesen, Prof. Dr. +49(0)251 83 ext 56859 a.g.dinnesen@uni-muenster.de

Locations
Layout table for location information
Germany
Department of Phoniatrics and Pediatric Audiology, University Hospital Münster Recruiting
Münster, Germany, 48149
Contact: Peter Matulat    +49(0)251 83 ext 56898    matulat@uni-muenster.de   
Contact: Antoinette G Dinnesen, Prof. Dr.    +49(0)251 83 ext 56859    a.g.dinnesen@uni-muenster.de   
Principal Investigator: Peter Matulat         
Principal Investigator: Antoinette G Dinnesen, Prof. Dr.         
Sub-Investigator: Claus-Michael Schmidt, Dr         
Switzerland
Phonak AG Recruiting
Stäfa, Switzerland, 8712
Contact: Jürgen Tchorz, Dr    +41 1928 ext 0101    juergen.tchorz@phonak.ch   
Sponsors and Collaborators
University Hospital Muenster
Phonak AG, Switzerland
Investigators
Layout table for investigator information
Principal Investigator: Peter Matulat Department of Phoniatrics and Pediatric Audiology, University Hospital Münster
Study Director: Antoinette G Dinnesen, Prof. Dr. Department of Phoniatrics and Pediatric Audiology, University Hospital Münster
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
ClinicalTrials.gov Identifier: NCT00167128    
Other Study ID Numbers: phonpaed002
First Posted: September 14, 2005    Key Record Dates
Last Update Posted: August 15, 2007
Last Verified: May 2006
Keywords provided by University Hospital Muenster:
Auditory Processing Disorder
speech-in-noise intelligibility
Additional relevant MeSH terms:
Layout table for MeSH terms
Auditory Perceptual Disorders
Auditory Diseases, Central
Retrocochlear Diseases
Ear Diseases
Otorhinolaryngologic Diseases
Brain Diseases
Central Nervous System Diseases
 Nervous System Diseases
Perceptual Disorders
Neurobehavioral Manifestations
Neurologic Manifestations
Cognition Disorders
Neurocognitive Disorders
Mental Disorders